The mission centers on identifying transformative products and opportunities with compelling risk-reward profiles. Analysts specialize by disease and modality, while diverse sourcing funnels—including international outreach and royalty strategies—enhance idea generation. The focus remains on early-stage investments, where potential for significant returns lies in uncovering misunderstood assets and supporting them through their lifecycle.
